Aarvik Therapeutics, Inc. — Form D
Aarvik Therapeutics, Inc. of Hayward, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-09-02. The offering totals $8.3M, of which $8.3M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2021-09-02
- Form: D
- Accession: 0001881431-21-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $8.3M
- Amount sold: $8.3M
- Investors: 112
- Date of first sale: 2021-08-18
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-412250
Issuer
- Name: Aarvik Therapeutics, Inc.
- CIK: 0001881431
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 31363 Medallion Drive, Hayward, CA, 94544
- Phone: 408 741-1889
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Anula Jayasuriya | Director | San Francisco, CA |
| Sachdev Sidhu | Director | Hayward, CA |
| Jagath Reddy Junutula | Director | Hayward, CA |
| Jagath Reddy Junutula | Executive Officer | Hayward, CA |
| Ram Kalakoti Reddy | Director | Hayward, CA |
| Richard Scheller | Director | Hayward, CA |
Other filings by this issuer (1)
More